European Central Bank holds rates steady as economy shows resilience

European Central Bank holds rates steady as economy shows resilience


The European Central Bank has kept interest rates on hold, as expected, at its latest meeting on Thursday.

The central bank held its key deposit facility rate at 2% for the third consecutive time, having last cut rates in June. The trim, which coincided with euro zone inflation hitting the ECB’s target rate of 2%, was part of a rate-cutting cycle that has brought rates down from last year’s record high of 4%.

The ECB said in a statement Thursday that “inflation remains close to the 2% medium-term target and the Governing Council’s assessment of the inflation outlook is broadly unchanged.”

“The economy has continued to grow despite the challenging global environment. The robust labour market, solid private sector balance sheets and the Governing Council’s past interest rate cuts remain important sources of resilience,” it said.

It cautioned, however, that “the outlook is still uncertain, owing particularly to ongoing global trade disputes and geopolitical tensions.”

While the euro zone inflation rate inched up to 2.2% in September, up from 2% the previous month, the rise was attributed to an increase in services prices and economists had said the central bank was likely to remain cautious about meddling with rates right now.

Expectations that the ECB would keep rates on hold were reinforced earlier Thursday when preliminary euro zone growth data showed the economy had grown 0.2% in the third quarter, from the previous three month period. The figure was above expectations and showed that economic activity remained resilient, despite prevailing uncertainty over business activity following U.S. trade tariffs.

ECB President Christine Lagarde told reporters that while the services sector continued to grow — boosted by strong tourism and a pick-up in digital services — manufacturing had been “held back by higher tariffs, still heightened uncertainty and a stronger euro.”

She added that the divergence between external and internal demand is “likely to persist” in the near term. “The economy should benefit from consumers spending more as real incomes rise,” Lagarde noted.

A projected illumination marking the 75th anniversary of the Schuman Declaration, on the Grossmarkthalle building at the European Central Bank headquarters in Frankfurt, Germany, on May 9, 2025.

Alex Kraus/Bloomberg via Getty Images

After the ECB’s announcement, the euro reversed earlier gains to trade 0.26% below the dollar, at $1.1571.

“What a boring announcement,” Mike Coop, chief investment officer of EMEA at Morningstar Wealth, told CNBC Thursday.

“It does belie the fact that inflation actually has gone back to being pretty much well behaved … so it’s hardly surprising that they’re not feeling in a rush to change rates,” he told CNBC’s “Decision Time.”

“The bigger picture, I think, is that Europe is still adapting to the triple shocks of the removal of cheap energy, worse trade terms with the U.S. and the need to spend more on defense. On top of those three things, you also have now the U.S. sucking investment out of other parts of the world, so Europe hasn’t had that stimulus, that we’ve seen in the U.S., to support growth,” he told CNBC’s Karen Tso.

Data dependence

The central bank has repeatedly said it will take a meeting-by-meeting and data dependent approach to rate setting, and it repeated this stance on Thursday. However, top ECB board members told CNBC this month that the easing cycle is close to, or at its end.

Martin Kocher, European Central Bank Governing Council member and governor at Austrian National Bank, said that as long as nothing “drastic” happens, Europe is “OK.”

“At the moment, I think we’re in a good place. So, there’s no reason to change anything, as long as there are no changes that force us to do something, Kocher said, speaking to CNBC’s Karen Tso at the IMF and World Bank annual meetings in Washington.

“And if you take the larger picture, yes, the easing cycle is close to an end or at its end, but there’s no reason to pre-commit at that stage.”

In a separate interview, ECB Governing Council member François Villeroy de Galhau said he recommended “agile pragmatism” when it comes to the path for interest rates, adding: “We are in a good position … but a good position is not a fixed position.”

A majority of economists polled in mid-October by Reuters said the ECB would hold its deposit rate this year, while 45 of 79 economists polled (57%) saw no change by the end of 2026.

— CNBC’s Tasmin Lockwood and Leonie Kidd contributed reporting to this story.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More